Back to Search
Start Over
How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study.
- Source :
-
International Journal of Urology . Feb2006, Vol. 13 Issue 2, p127-131. 5p. 4 Charts, 4 Graphs. - Publication Year :
- 2006
-
Abstract
- Three hundred Japanese patients with benign prostatic hyperplasia (BPH) who started an α1-adrenoceptor blocker, tamsulosin, between 1993 and 1996 were followed for 3.0 ± 3.3 years (mean ± SD) to determine whether an association existed between the disease severities measured prior to the tamsulosin treatment and the timing at which the invasive therapy was implemented. Patients with a lower quality of life (QOL) index or maximum urinary flow rate (Qmax) were transferred for invasive therapy earlier than those with less severe BPH. The International Prostate Symptom Score (I-PSS) was also associated, but apparently to a lesser extent, with the timing of the invasive therapy. Finally, the overall severity evaluated using all of the above three indices, I-PSS, QOL index, and Qmax, in accordance with the ‘Severity Criteria for BPH’ issued by the Japanese Urological Association, was found to be a good measure for predicting the prognosis of patients with BPH treated with tamsulosin. [ABSTRACT FROM AUTHOR]
- Subjects :
- *PROSTATE hypertrophy
*PATIENTS
*QUALITY of life
*THERAPEUTICS
*ALPHA adrenoceptors
Subjects
Details
- Language :
- English
- ISSN :
- 09198172
- Volume :
- 13
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- International Journal of Urology
- Publication Type :
- Academic Journal
- Accession number :
- 19967379
- Full Text :
- https://doi.org/10.1111/j.1442-2042.2006.01245.x